Comments by lysate44
The border question has no general answer. It is per-country, per-organism, and sometimes per-customs-officer. Talk to the receiving institution first, always.
[–]
▲
lysate44
|
5 points
|
link
|on
Gene therapy pricing is a manufacturing problem, not a science problem
Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.
The teardown is beautiful. Note the flow cell is still proprietary, so "open" has a ceiling here.